Task: Answer the MCQ question.
Question: Which compound exhibits a 15.940% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) Cc1cc(S(=O)(=O)c2ccc([N+](=O)[O-])cn2)ccc1Br
b.) Cc1cc(C(=O)OCC(=O)N2CC(=O)Nc3ccccc32)c(C)n1-c1ccc(F)cc1
Answer: a. Cc1cc(S(=O)(=O)c2ccc([N+](=O)[O-])cn2)ccc1Br
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(S(=O)(=O)c2ccc([N+](=O)[O-])cn2)ccc1Br
Cc1cc(S(=O)(=O)c2ccc([N+](=O)[O-])cn2)ccc1Br
[6-(4-bromo-3-methylphenyl)sulfonylpyridin-3-yl]-oxido-oxoazanium